These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23640572)

  • 1. Role of p21-activated kinases in cardiovascular development and function.
    Kelly ML; Astsaturov A; Chernoff J
    Cell Mol Life Sci; 2013 Nov; 70(22):4223-8. PubMed ID: 23640572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of p21-activated kinases (PAKs).
    Rudolph J; Crawford JJ; Hoeflich KP; Wang W
    J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P21 activated kinase signaling in cancer.
    Rane CK; Minden A
    Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.
    Shao YG; Ning K; Li F
    World J Gastroenterol; 2016 Jan; 22(3):1224-35. PubMed ID: 26811660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
    McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
    Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P21-activated kinase in inflammatory and cardiovascular disease.
    Taglieri DM; Ushio-Fukai M; Monasky MM
    Cell Signal; 2014 Sep; 26(9):2060-9. PubMed ID: 24794532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21-Activated kinase 1 (PAK1) in aging and longevity: An overview.
    Amirthalingam M; Palanisamy S; Tawata S
    Ageing Res Rev; 2021 Nov; 71():101443. PubMed ID: 34390849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-dependent activity-based conformational changes in P21-activated kinase family members and screening of novel ATP competitive inhibitors.
    Gul M; Fakhar M; Najumuddin ; Rashid S
    PLoS One; 2019; 14(11):e0225132. PubMed ID: 31738805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of p21-activated kinases in pancreatic cancer.
    Yeo D; He H; Baldwin GS; Nikfarjam M
    Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.
    Licciulli S; Maksimoska J; Zhou C; Troutman S; Kota S; Liu Q; Duron S; Campbell D; Chernoff J; Field J; Marmorstein R; Kissil JL
    J Biol Chem; 2013 Oct; 288(40):29105-14. PubMed ID: 23960073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21-activated kinase inhibitors.
    Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
    Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21-Activated kinase inhibitors: a patent review.
    Crawford JJ; Hoeflich KP; Rudolph J
    Expert Opin Ther Pat; 2012 Mar; 22(3):293-310. PubMed ID: 22404134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
    Ong CC; Gierke S; Pitt C; Sagolla M; Cheng CK; Zhou W; Jubb AM; Strickland L; Schmidt M; Duron SG; Campbell DA; Zheng W; Dehdashti S; Shen M; Yang N; Behnke ML; Huang W; McKew JC; Chernoff J; Forrest WF; Haverty PM; Chin SF; Rakha EA; Green AR; Ellis IO; Caldas C; O'Brien T; Friedman LS; Koeppen H; Rudolph J; Hoeflich KP
    Breast Cancer Res; 2015 Apr; 17(1):59. PubMed ID: 25902869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho family GTPase signaling through type II p21-activated kinases.
    Chetty AK; Ha BH; Boggon TJ
    Cell Mol Life Sci; 2022 Nov; 79(12):598. PubMed ID: 36401658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21-activated kinase 1: PAK'ed with potential.
    Ong CC; Jubb AM; Zhou W; Haverty PM; Harris AL; Belvin M; Friedman LS; Koeppen H; Hoeflich KP
    Oncotarget; 2011 Jun; 2(6):491-6. PubMed ID: 21653999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.
    Ha BH; Morse EM; Turk BE; Boggon TJ
    J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window.
    Rudolph J; Murray LJ; Ndubaku CO; O'Brien T; Blackwood E; Wang W; Aliagas I; Gazzard L; Crawford JJ; Drobnick J; Lee W; Zhao X; Hoeflich KP; Favor DA; Dong P; Zhang H; Heise CE; Oh A; Ong CC; La H; Chakravarty P; Chan C; Jakubiak D; Epler J; Ramaswamy S; Vega R; Cain G; Diaz D; Zhong Y
    J Med Chem; 2016 Jun; 59(11):5520-41. PubMed ID: 27167326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational insight into the mechanisms of action and selectivity of Afraxis PAK inhibitors.
    Han D; Wang H; Cui W; Zhang B; Chen BZ
    Future Med Chem; 2020 Mar; 12(5):367-385. PubMed ID: 32064922
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL.
    Siekmann IK; Dierck K; Prall S; Klokow M; Strauss J; Buhs S; Wrzeszcz A; Bockmayr M; Beck F; Trochimiuk M; Gottschling K; Martens V; Khosh-Naucke M; Gerull H; Müller J; Behrmann L; Blohm M; Zahedi RP; Jeremias I; Sickmann A; Nollau P; Horstmann MA
    Blood Adv; 2018 Oct; 2(19):2554-2567. PubMed ID: 30301811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Rac/Cdc42/PAK pathway in cytoskeletal rearrangements.
    Szczepanowska J
    Acta Biochim Pol; 2009; 56(2):225-34. PubMed ID: 19513348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.